Viewing StudyNCT00299702



Ignite Creation Date: 2024-05-05 @ 4:40 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00299702
Status: COMPLETED
Last Update Posted: 2011-12-30
First Post: 2006-03-03

Brief Title: Evaluation of Effectiveness of Risperdal Consta Compared to Abilify Over a Two-year Period in Patients With Schizophrenia
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Schizophrenia
Psychotic Disorders
Keywords:
Name View
Schizophrenia View
Relapse View
Remission View
Treatment Outcome View
long-acting injectable View